Quick Answer
Beta Bionics, Inc. reported Earnings Per Share Diluted of $1.81 (loss) per share for the year ending 2025.
- Beta Bionics, Inc. showed an increase of +79.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Beta Bionics, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Beta Bionics, Inc.'s Earnings Per Share Diluted has grown by 78.2%.
- Historical annual values: Fiscal year 2025: $1.81 (loss) per share | Fiscal year 2024: $8.60 (loss) per share | Fiscal year 2023: $8.31 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: